Zobrazeno 1 - 10
of 54
pro vyhledávání: '"George Eisele"'
Autor:
Margaret Kiser, Xiaotong Zhang, Anca Tilea, Fredric O. Finkelstein, Rajiv Saran, Peter Kotanko, George Eisele, Nathan W. Levin, Brenda W. Gillespie, B Kumar, Sanjay Rajagopalan
Publikováno v:
Clinical Nephrology. 73:104-114
BACKGROUND There has been limited research on sleep quality (SQ) in CKD. METHODS This prospective cohort study of adults with CKD Stages 3 - 5 at four US centers collected self-reported SQ information from the Kidney Disease Quality of Life (KDQOL) i
Autor:
George Eisele, George R. Bailie
Publikováno v:
Seminars in Dialysis. 9:417-423
Autor:
George R. Bailie, Erik Roys, Sally Burrows-Hudson, Margaret Kiser, Lei Liu, George Eisele, Rajiv Saran, Frederick Finkelstein, Friedrich K. Port, Robert R. Wolfe
Publikováno v:
Nephrology Dialysis Transplantation. 20:1110-1115
Background. Patients with chronic kidney disease (CKD) stages 2–5 are known to suffer numerous complications and co-morbidities associated with kidney disease. The medication prescription patterns in this population are not well understood. We repo
Autor:
Margaret Kiser, Lei Liu, Erik Roys, George R. Bailie, Rachel L. Perlman, Fredric O. Finkelstein, Rajiv Saran, Sally Burrows-Hudson, Joseph M. Messana, George Eisele, Sanjay Rajagopalan, Friedrich Port
Publikováno v:
Seminars in Dialysis. 16:418-423
Chronic kidney disease (CKD) is a significant public health problem: every year the number of Americans living with CKD and requiring renal replacement therapy increases. In addition, individuals with CKD have substantially increased morbidity and mo
Autor:
Rachelle Seguin, Ruth Wilson, Gene Bont, Patrick Caulfield, Mary Rogerson, Edwin B. Toffelmire, Marshall Godwin, Ross Morton, George Eisele, Peter Burrows, Peter White
Publikováno v:
American Journal of Kidney Diseases. 38:42-48
The objective of this study is to determine how patient age, sex, creatinine level, and comorbidity affect referral decisions for the treatment of end-stage renal disease (ESRD) and whether these decisions are affected by physician characteristics in
Publikováno v:
American Journal of Kidney Diseases. 33:111-117
Ceftazidime is currently recommended as an alternative first-line agent in the treatment of peritonitis and for Pseudomonas peritonitis. The pharmacokinetics of intermittent intraperitoneal (i.p.) ceftazidime have been poorly characterized. This stud
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 19:65-70
Objective To investigate the pharmacokinetic parameters of intermittent intraperitoneal (IP) cefazolin, and recommend a cefazolin dosing regimen in continuous ambulatory peritoneal dialysis (CAPD) patients. Design Prospective nonrandomized open study
Publikováno v:
Clinical Drug Investigation. 15:57-60
Publikováno v:
Clinical Drug Investigation. 14:12-15
Iron-dextran may be administered during haemodialysis by slow infusion through the venous access port for the management of iron deficiency in patients treated with erythropoietin. This technique is time-efficient and convenient. The degree to which
Serum sodium levels and patient outcomes in an ambulatory clinic-based chronic kidney disease cohort
Autor:
Sang-Woong Han, Nathan W. Levin, Fredric O. Finkelstein, Brenda W. Gillespie, Margaret Kiser, Anca Tilea, Rajiv Saran, George Eisele, Peter Kotanko
Publikováno v:
American journal of nephrology. 41(3)
Background: Chronic kidney disease (CKD) patients are prone to both hypo- and hypernatremia. Little has been published on the epidemiology of hypo- and hypernatremia in ambulatory patients with non-dialysis CKD. Methods: Data collected in two contemp